Although we are making considerable progress in the fight against cancer, we still have a long way to go. Often, the best new information about cancer comes from animals participating in a clinical trial.
If you do not live in our region of the country, you may also check with the Veterinary Cancer Society to learn about trials in your area.
We are currently recruiting dogs with multicentric lymphoma for multiple ongoing clinical studies.
For dogs with urinary bladder cancer (TCC) affecting the bladder and/or urethra. The study is aimed at learning how the dog’s immune system can be stimulated to attack the cancer.
Clinical evaluation of propranolol in combination with doxorubicin for the treatment of splenic hemangiosarcoma in dogs.
The WCORC and Purdue Institute for Cancer Research have recently launched a research program in canine osteosarcoma to identify new, effective therapies in dogs that will improve cure rates for both dogs and humans with this cancer. Our current focus is on collecting tumor tissues from dogs undergoing amputation to analyze them for susceptibility to novel drugs. A financial incentive of $500 per dog is available to help offset the cost of amputation to the owners of dogs contributing to this research.
Therapeutic trials are expected within the next 1–2 years.